Maze Therapeutics, Inc. Common Stock (MAZE) — Long-term Investment Intensity
Maze Therapeutics, Inc. Common Stock (MAZE) has a Long-term Investment Intensity of 4.6% as of December 2025. Long-term investments of $18.11 Million represent 4.6% of total assets of $397.13 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Maze Therapeutics, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Maze Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 4.6%, reflecting long-term investments of $18.11 Million against total assets of $397.13 Million USD. Also explore Maze Therapeutics, Inc. Common Stock balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MAZE company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.6% | $18.11 Million | $397.13 Million | — |